U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07391371) titled 'Alternate-day Versus Daily Oral Iron Therapy in Children With Iron Deficiency Anaemia' on Jan. 29.
Brief Summary: The goal of this clinical trial is to find out whether Iron (III)-hydroxide polymaltose complex (IPC) given on an alternate-day schedule works as well as daily dosing in treating iron deficiency anaemia in children. The study will also look at the safety and tolerability of IPC.
The main questions this study aims to answer are:
Does alternate-day oral IPC improve haemoglobin levels and serum ferritin level as effectively as daily oral IPC?
Does alternate-day dosing reduce gastrointestinal side effects compared to daily...